Category: Active Surveillance
The Impact of the Recommendation Against PSA Screening
In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a recommendation against routine PSA screening for otherwise healthy men. Almost immediately, prostate cancer support organizations and hundreds of clinical professionals raised an outcry. While acknowledging that the non-prostate cancer specific blood test often led to over-detection and over-treatment of indolent prostate cancer, countless lives keep readingWhat Makes A Good Prostate Cancer Screening Test?
At this year’s American Urological Association annual meeting in Orlando, FL, there were numerous courses that offer continuing education credits for physicians. One of the courses was directed by Dr. J. Stephen Jones who, for five years, served as Chair of the Urology Department at the Cleveland Clinic. He is very well respected in the keep reading
Imaging to Support the Increase in Active Surveillance
Beyond doubt, the interest in Active Surveillance for prostate cancer (AS, also called Expectant Management) is on the rise. A number of converging factors are driving the increase: Better early detection and diagnosis of low-risk disease Emerging science on which cell lines are unlikely to progress into lethal disease Broader awareness of the risks of keep reading
